|Patient-derived xenograft models: an emerging platform for translational cancer research|
M Hidalgo, F Amant, AV Biankin, E Budinská, AT Byrne, C Caldas, ...
Cancer discovery 4 (9), 998-1013, 2014
|Dissociation between steroid receptor expression and cell proliferation in the human breast|
RB Clarke, A Howell, CS Potten, E Anderson
Cancer research 57 (22), 4987-4991, 1997
|Aberrant activation of notch signaling in human breast cancer|
S Stylianou, RB Clarke, K Brennan
Cancer research 66 (3), 1517-1525, 2006
|Identification of a putative intestinal stem cell and early lineage marker; musashi‐1|
CS Potten, C Booth, GL Tudor, D Booth, G Brady, P Hurley, G Ashton, ...
Differentiation: REVIEW 71 (1), 28-41, 2003
|Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor|
H Harrison, G Farnie, SJ Howell, RE Rock, S Stylianou, KR Brennan, ...
Cancer research 70 (2), 709-718, 2010
|Mammary stem cells and breast cancer—role of Notch signalling|
G Farnie, RB Clarke
Stem cell reviews 3 (2), 169-175, 2007
|Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways|
G Farnie, RB Clarke, K Spence, N Pinnock, K Brennan, NG Anderson, ...
Journal of the National Cancer Institute 99 (8), 616-627, 2007
|A putative human breast stem cell population is enriched for steroid receptor-positive cells|
RB Clarke, K Spence, E Anderson, A Howell, H Okano, CS Potten
Developmental biology 277 (2), 443-456, 2005
|Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer|
SA Eccles, EO Aboagye, S Ali, AS Anderson, J Armes, F Berditchevski, ...
Breast Cancer Research 15 (5), 1-37, 2013
|Estrogen receptor-positive proliferating cells in the normal and precancerous breast|
BS Shoker, C Jarvis, RB Clarke, E Anderson, J Hewlett, MPA Davies, ...
The American journal of pathology 155 (6), 1811-1815, 1999
|A detailed mammosphere assay protocol for the quantification of breast stem cell activity|
FL Shaw, H Harrison, K Spence, MP Ablett, BM Simões, G Farnie, ...
Journal of mammary gland biology and neoplasia 17 (2), 111-117, 2012
|Interrogating open issues in cancer precision medicine with patient-derived xenografts|
AT Byrne, DG Alférez, F Amant, D Annibali, J Arribas, AV Biankin, A Bruna, ...
Nature Reviews Cancer 17 (4), 254, 2017
|Risk determination and prevention of breast cancer|
A Howell, AS Anderson, RB Clarke, SW Duffy, DG Evans, ...
Breast Cancer Research 16 (5), 1-19, 2014
|The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone|
IJ Laidlaw, RB Clarke, A Howell, AW Owen, CS Potten, E Anderson
Endocrinology 136 (1), 164-171, 1995
|Estrogen responsiveness and control of normal human breast proliferation|
E Anderson, RB Clarke, A Howell
Journal of mammary gland biology and neoplasia 3 (1), 23-35, 1998
|The centrosomal kinase Nek2 displays elevated levels of protein expression in human breast cancer|
DG Hayward, RB Clarke, AJ Faragher, MR Pillai, IM Hagan, AM Fry
Cancer research 64 (20), 7370-7376, 2004
|Steroid receptors and cell cycle in normal mammary epithelium|
E Anderson, RB Clarke
Journal of mammary gland biology and neoplasia 9 (1), 3-13, 2004
|Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and-independent mechanisms|
JK Singh, G Farnie, NJ Bundred, BM Simoes, A Shergill, G Landberg, ...
Clinical cancer research 19 (3), 643-656, 2013
|Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells|
JK Singh, BM Simões, SJ Howell, G Farnie, RB Clarke
Breast Cancer Research 15 (4), 210, 2013
|Origins of breast cancer subtypes and therapeutic implications|
AH Sims, A Howell, SJ Howell, RB Clarke
Nature Clinical Practice Oncology 4 (9), 516-525, 2007